Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Systemic Lupus Erythematosus Clinical Trial
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
Status: Enrolling, Phase III
Updated: 12/31/1969
Arthritis Clinic Of Northern Va, P.C.
mi
from
Arlington, VA
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
Status: Enrolling, Phase III
Updated: 12/31/1969
Integral Rheumatology & Immunology Specialists
mi
from
Plantation, FL
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
Status: Enrolling, Phase III
Updated: 12/31/1969
Office: Dr Robin K Dore
mi
from
Tustin, CA
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
Status: Enrolling, Phase III
Updated: 12/31/1969
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
Click here to add this to my saved trials
Hematology, Neurology Clinical Trial
Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lifelong Vision Foundation
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
OSU Eye Physicians and Surgeons, LLC.
mi
from
Columbus, OH
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwest Retina
mi
from
Dublin, OH
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Colorado Retina Associates
mi
from
Golden, CO
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwest Eye Institute
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Georgia Retina, P.C.
mi
from
Marietta, GA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Byers Eye Institute at Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Black Hills Eye Institute
mi
from
Rapid City, SD
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Riverside Medical Center
mi
from
Riverside, CA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California Davis Eye Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Retinal Consultants, PC
mi
from
Traverse City, MI
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Palmetto Retina Center, LLC
mi
from
Florence, SC
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Columbia University Medical Center Herbert Irving Pavilion
mi
from
New York, NY
Click here to add this to my saved trials
Liver Cirrhosis, Biliary Clinical Trial
Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment
Status: Enrolling, Phase IV
Updated: 12/31/1969
UPMC Center For Liver Diseases
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Liver Cirrhosis, Biliary Clinical Trial
Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment
Status: Enrolling, Phase IV
Updated: 12/31/1969
Swedish Organ Transplant and Liver Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mary Greeley Medical Center
mi
from
Ames, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Alaska Breast Care and Surgery LLC
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Katmai Oncology Group
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Medical Center-Weiler Hospital
mi
from
Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Canton
mi
from
Canton, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bay Area Hospital
mi
from
Coos Bay, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hematology Oncology Associates of Central New York PC-East Syracuse
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Crossroads Cancer Center
mi
from
Effingham, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ephrata Cancer Center
mi
from
Ephrata, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Roger Maris Cancer Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Geisinger Medical Center-Cancer Center Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Novant Health Oncology Specialists-Kernersville
mi
from
Kernersville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Macomb
mi
from
Macomb, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bon Secours Memorial Regional Medical Center
mi
from
Mechanicsville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Idaho Urologic Institute - Meridian
mi
from
Meridian, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Patrick Hospital - Community Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Toledo Clinic Cancer Centers - Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
New Ulm Medical Center
mi
from
New Ulm, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Oncology Hematology Consultants
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Regional Hematology and Oncology PA
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Pittsburgh Cancer Institute (UPCI)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Christus Saint Vincent Regional Cancer Center
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Medical Center-Ballard Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Medical Center-First Hill
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Geisinger Medical Group
mi
from
State College, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Novant Health Oncology Specialists-Statesville
mi
from
Statesville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakeview Hospital
mi
from
Stillwater, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Missouri Baptist Sullivan Hospital
mi
from
Sullivan, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Care Specialists of Illinois-Swansea
mi
from
Swansea, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint John Macomb-Oakland Hospital
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Methodist West Hospital
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer System-Yelm
mi
from
Yelm, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rush-Copley Healthcare Center
mi
from
Yorkville, IL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Status: Enrolling
Updated: 12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Mindfulness for Resilience in Early Life
Status: Enrolling
Updated: 12/31/1969
Laureate Institute for Brain Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
MDM2 Inhibitor DS-3032b and Low-Dose Cytarabine in Treating Participants With Newly Diagnosed Recurrent or Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Healthy Clinical Trial
Enduring Exercise Habits
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Tennessee Oncology-Chattanooga
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Colorado Heart & Vascular, P.C.
mi
from
Lakewood, CO
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Vincent Heart Clinic Arkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
North Memorial Heart and Vascular Institute
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Delmarva Heart Research Foundation
mi
from
Salisbury, MD
Click here to add this to my saved trials
Iron Deficiency Anemia Clinical Trial
A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Development Associates, LLC
mi
from
Springfield Gardens, NY
Click here to add this to my saved trials
Erectile Dysfunction Clinical Trial
Penile Lengthening Pre-Penile Prosthesis Implantation
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Desoto, TX
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants
Status: Enrolling, Phase I
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants
Status: Enrolling, Phase I
Updated: 12/31/1969
Local Institution
mi
from
Knoxville, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants
Status: Enrolling, Phase I
Updated: 12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Oklahoma Stephenson Cancer Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder Clinical Trial
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
Status: Enrolling, Phase II
Updated: 12/31/1969
Bluegrass Epilepsy Research
mi
from
Lexington, KY
Click here to add this to my saved trials
Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder Clinical Trial
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
Status: Enrolling, Phase II
Updated: 12/31/1969
Minnesota Epilepsy Group
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Aphasia Clinical Trial
Translation and Clinical Implementation of a Test of Language and Short-term Memory in Aphasia.
Status: Enrolling, Phase
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Aphasia Clinical Trial
Translation and Clinical Implementation of a Test of Language and Short-term Memory in Aphasia.
Status: Enrolling, Phase
Updated: 12/31/1969
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cystic Fibrosis in Children Clinical Trial
Developing e-Health Systems to Improve Growth and Nutrition in CF
Status: Enrolling
Updated: 12/31/1969
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials